The vaccine candidate under trial by University of Oxford scientists in collaboration with AstraZeneca is the furthest in the process of trials and, according to a report in ‘The Times’, it could be given the required clearances by Christmas. UK government sources said that a full vaccine roll-out programme for adults could take 6 months or less after approval.

Read more here:: India News Times